|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.8590 - 0.9020|
|52 Week Range||0.6030 - 1.9080|
|Beta (3Y Monthly)||2.78|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) through its wholly-owned subsidiary Emblem Cannabis Corporation, today announced that Emblem-branded cannabis oils are now available online through Shoppers Drug Mart to patients with a valid medical authorization. Emblem’s state-of-the-art indoor cannabis cultivation facility and Product Innovation Centre is located in Paris, Ontario.
Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia” or the “Company”) has completed Phase I construction and retrofitting of its Niagara Greenhouse facility (“Niagara”) located in Grimsby, Ontario. The Company expects to complete Phase II of the construction and retrofitting on the balance of the facility in late Q1 or early Q2 2019. The Company has also submitted the facility’s Evidence Package to Health Canada, marking the final stage in the Cultivation Licence application process.
Cannabis markets saw a huge boom in 2018, but wait for what comes next, and one small company aiming for a big gross profit margin may lead the charge
The consolidation in the cannabis industry continues as companies not just in the United States are making deals. The company will give 0.8377 shares per each share of Emblem, which represents C$1.21 per Emblem share and a premium of 27 percent based on the closing prices of Aleafia and Emblem on the TSX Venture Exchange on Dec. 18. Cannabis investors can't miss the Benzinga Cannabis Capital Conference, the No. 1 networking event for institutional capital and the leading cannabis companies.
CORAL GABLES, FL / ACCESSWIRE / December 19, 2018 / The price of marijuana can be a very intelligible indicator as to how the market will respond to new trends. As legal markets have gone into place in the U.S., Canada and around the world, we are quickly seeing just how volatile the prices of pure marijuana can be. As more nations around the world pass legislation in favor of marijuana, the cannabis industry may see impressive gains in the near-future.Premier Health Group (OTC:PHGRF) (CSE:PHGI), Emblem Corp (EMMBF), New Age Beverages Corp (NBEV), and Aphria Inc (APHA) represent 4 cannabis stocks that have seen even more activity following ongoing development of legislation.
Combination will create Canada’s largest medical cannabis clinic network with access to 40 medical clinics and education centres;Aleafia patients to access Emblem’s.
Aleafia Health Inc. announced Wednesday a deal to buy fellow Canada-based cannabis company Emblem Corp. in a deal that values Emblem at about C$173.2 million ($128.8 million). Under terms of the deal, Emblem shareholders will receive 0.8377 Aleafia shares for each Emblem share they own. Based on Tuesday's stock closing prices in Canada, that values Emblem shares at C$1.206, or a 27% premium. The deal, which the companies say will create the largest medical cannabis clinic network, gives Aleafia access to Emblem's high-margin derivative products, including capsules, oils and oral sprays. The deal also helps Aleafia leverage Emblem's Health Canada License to sell medical cannabis products directly to patients. "Emblem's product leadership in the medical and adult-use sectors and highly coveted supply agreements will perfectly complement Aleafia's cannabis production and clinic operations," said Aleafia Chief Executive Geoffrey Benic. "This is a transformative transaction that positions Aleafia as a global cannabis leader." Aleafia's U.S.-listed shares have shed 27% over the past three months and Emblem's stock has tumbled 45%, while the ETFMG Alternative Harvest ETF has dropped 36% and the S&P 500 has lost 12%.
Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, today announced the launch of a new line of 10mg Emblem Oil Capsules, providing its growing list of 6,000+ patients with a pre-dosed treatment format. The 10mg Emblem Oil Capsules offer a consistent patient experience formulated with three chemovar specific formats - High THC (10mg THC per capsule), High CBD (10 mg CBD per capsule) and Balanced (6mg THC/10 mg CBD per capsule).
Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) today announced the appointment of Connie A. Stefankiewicz and Loreto Grimaldi to its Board of Directors (the “Board”) following Emblem’s annual and special shareholders’ meeting. Harvey Shapiro, current chair, and Maxim Zavet have stepped down from the Board, and the Board would like to thank them for their immense contributions since Emblem’s inception. Ms. Stefankiewicz and Mr. Grimaldi will join current Board members Daniel Milliard, Jeffrey Fineberg, John H. Stewart, Terry Johnson and Nick Dean.
TORONTO, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX:EMMBF) ("Emblem" or the "Company"), today announced that, through its wholly-owned subsidiary Emblem Cannabis Corporation (“ECC”), it has signed a definitive agreement with German pharmaceutical wholesaler Acnos Pharma GmbH (“Acnos”) in respect to launching a joint venture under the name “Emblem Germany” (the “JV”) for the purpose of exporting Emblem-branded cannabis products from Canada into Germany. The JV – owned 60% by ECC and 40% owned by Acnos – will allow Emblem to commence exporting its products to Germany, with first deliveries expected to be made in mid-2019.
VIDEO + B-ROLL: Emblem Corp. CEO Nick Dean welcomes Canada-wide adult-use cannabis legalization
TORONTO , Oct. 15, 2018 /CNW/ - Emblem Corp. (TSXV: EMC, OTCQX:EMMBF) ("Emblem" or the "Company") today announced that it will segregate CDN $5 million of its current cash holdings to establish what it is calling the Patient Access Investment Fund (the "Fund"), the interest from which will be used to help offset some of the cost of the excise tax that will be applied to medical cannabis products, effective October 17, 2018 . On October 17 , the Access to Cannabis for Medical Purposes Regulations ("ACMPR") will be replaced by the Cannabis Act, and all Licensed Producers will be required to collect and submit a federal cannabis excise tax to the government. The standard rate tax is the greater of $1.00 /gram equivalent or 10% of the purchase price, with some provinces requiring an additional excise duty adjustment on top, which can range as high as 19.3% (the "New Excise Tax").
ATLANTA, GA / ACCESSWIRE / September 24, 2018 / CannaInvestor Magazine, the leading industry investment magazine for cannabis investors, analysts, executives, entrepreneurs, and financial media, announced ...
CORAL GABLES, FL / ACCESSWIRE / September 18, 2018 / Cannabis and marijuana stocks are striking up conversation in the market. The looming date in mid October has a number of investors speculating on what is to come for the cannabis industry once Canada is legally selling recreational marijuana across the country. Further to this, a larger cannabis company and one that has recently gone public in the US, Tilray (TLRY) will be "breaking down barriers" and importing medical cannabis into the US.A number of marijuana stocks are heading higher this month and include GTEC Holdings (GGTTF) (GTEC), Emblem Corp. (EMMBF) (EMC.V), and Green Thumb Industries (GTBIF)(TSX:GTII).